Rhenman & Partners Asset Management AB Cuts Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Rhenman & Partners Asset Management AB reduced its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,362,421 shares of the company’s stock after selling 8,726 shares during the quarter. Oscar Health comprises about 1.9% of Rhenman & Partners Asset Management AB’s investment portfolio, making the stock its 20th biggest position. Rhenman & Partners Asset Management AB owned 0.55% of Oscar Health worth $18,311,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. KBC Group NV raised its holdings in shares of Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after buying an additional 2,555 shares during the period. ORG Wealth Partners LLC purchased a new position in shares of Oscar Health in the 4th quarter valued at $100,000. Alberta Investment Management Corp purchased a new stake in shares of Oscar Health during the fourth quarter valued at about $138,000. Virtu Financial LLC purchased a new position in Oscar Health in the fourth quarter worth $140,000. Finally, Potentia Wealth purchased a new stake in Oscar Health in the fourth quarter valued at about $141,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Performance

NYSE OSCR opened at $12.99 on Friday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock’s fifty day moving average is $14.60 and its two-hundred day moving average is $15.84. Oscar Health, Inc. has a fifty-two week low of $12.25 and a fifty-two week high of $23.79. The firm has a market capitalization of $3.25 billion, a P/E ratio of -649.18 and a beta of 1.75.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on OSCR. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Jefferies Financial Group began coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $20.21.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.